Prost À la Denise J, Douard R, Malamut G, Mecheri F, Wind P
Department of General and Digestive Surgery, Avicenne AP-HP University Hospital, 125, rue de Stalingrad, 93009, Bobigny, France.
World J Surg. 2014 Feb;38(2):363-9. doi: 10.1007/s00268-013-2303-3.
Determining the cause of acute small bowel obstruction (SBO) in patients previously treated for cancer is necessary for adequate management, especially to avoid incorrectly classing the patient as palliative. We aimed to identify predictive factors for a malignant or a benign origin of SBO.
We retrospectively studied data for all patients with a prior history of cancer who had undergone operations for SBO between January 2002 and December 2011. Of the 124 patients included, 36 patients had a known cancer recurrence before surgery for SBO, whereas 88 had none.
Causes of SBO were benign (post-operative adhesions, post-irradiation strictures) in 68 patients (54.8 %) and malignant in 56 (45.2 %). Incomplete obstruction, acute clinical onset, non-permanent abdominal pain, a shorter period between primary cancer surgery and the first episode of obstruction, and a known cancer recurrence were significant predictors of a malignant SBO. Benign causes of SBO were observed in 72.8 % of patients who had no known cancer recurrence, but were observed in only 11.1 % of patients whose recurrences were known. In patients with cancer recurrence-related SBO, post-operative mortality was 28.6 %, with a median overall survival of 120 days. 1 month after surgery, 38 (67.8 %) of these patients tolerated oral intake.
A benign cause of SBO was observed in half of the patients with a prior history of cancer and in two-thirds of those without known recurrence. Even in the absence of bowel strangulation, surgery must be considered soon after failure of medical management to treat a possible adhesion-related SBO.
确定既往接受过癌症治疗的患者发生急性小肠梗阻(SBO)的病因对于进行充分的治疗十分必要,尤其是为了避免将患者错误地归类为姑息治疗。我们旨在确定SBO恶性或良性起源的预测因素。
我们回顾性研究了2002年1月至2011年12月期间所有既往有癌症病史且因SBO接受手术的患者的数据。纳入的124例患者中,36例在SBO手术前已知癌症复发,而88例无复发。
68例(54.8%)患者SBO的病因是良性的(术后粘连、放疗后狭窄),56例(45.2%)是恶性的。不完全梗阻、急性临床起病、非持续性腹痛、原发性癌症手术与首次梗阻发作之间的时间较短以及已知癌症复发是恶性SBO的重要预测因素。在无已知癌症复发的患者中,72.8%观察到SBO的良性病因,但在已知复发的患者中仅11.1%观察到。在与癌症复发相关的SBO患者中,术后死亡率为28.6%,中位总生存期为120天。术后1个月,这些患者中有38例(67.8%)能够耐受经口摄入。
在既往有癌症病史的患者中,一半患者以及三分之二无已知复发的患者观察到SBO的良性病因。即使没有肠绞窄,在药物治疗未能治疗可能的粘连相关SBO失败后,也必须尽快考虑手术。